Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma

BACKGROUND: Canine pancreatic carcinoma is a rare, aggressive tumour that is often diagnosed late in the course of disease. Effective treatment strategies have been elusive, and overall survival time is short. In humans, treatment with tyrosine kinase inhibitors alone, or in combination with IV gemc...

Descripción completa

Detalles Bibliográficos
Autores principales: Musser, Margaret L., Johannes, Chad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356392/
https://www.ncbi.nlm.nih.gov/pubmed/34380474
http://dx.doi.org/10.1186/s12917-021-02978-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356392/
https://www.ncbi.nlm.nih.gov/pubmed/34380474
http://dx.doi.org/10.1186/s12917-021-02978-8

Ejemplares similares